Log In
Print this Print this

IV lasmiditan (IV COL-144)

  Manage Alerts
Collapse Summary General Information
Company CoLucid Pharmaceuticals Inc.
DescriptionSelective agonist of serotonin (5-HT1F) receptor
Molecular Target Serotonin (5-HT1F) receptor
Mechanism of ActionSerotonin (5-HT1F) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat headache pain associated with migraine in adults in urgent care settings
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today